Ovarian hyperstimulation syndrome
- PMID: 19007627
- DOI: 10.1016/j.fertnstert.2008.08.034
Ovarian hyperstimulation syndrome
Abstract
This Educational Bulletin discusses the pathophysiology, risk factors, clinical features, and management and prevention associated with ovarian hyperstimulation syndrome (OHSS).
Similar articles
-
Ovarian hyperstimulation syndrome.Fertil Steril. 2006 Nov;86(5 Suppl 1):S178-83. doi: 10.1016/j.fertnstert.2006.08.021. Fertil Steril. 2006. PMID: 17055817 Review. No abstract available.
-
Ovarian hyperstimulation syndrome.Crit Care Clin. 2004 Oct;20(4):679-95, ix. doi: 10.1016/j.ccc.2004.05.003. Crit Care Clin. 2004. PMID: 15388196 Review.
-
[Ovarian hyperstimulation syndrome--prevention and treatment].Ugeskr Laeger. 1996 Dec 9;158(50):7205-9. Ugeskr Laeger. 1996. PMID: 9012033 Review. Danish.
-
Current management of ovarian hyperstimulation syndrome.Hosp Med. 2002 Sep;63(9):528-32. Hosp Med. 2002. PMID: 12357854 Review.
-
[Some aspects of ovarian hyperstimulation syndrome].Akush Ginekol (Sofiia). 2003;42(6):37-41. Akush Ginekol (Sofiia). 2003. PMID: 15067814 Review. Bulgarian.
Cited by
-
Concentration of soluble urokinase plasminogen activator receptor (suPAR) in the pre-ovulatory follicular fluid is associated with development of ovarian hyperstimulation syndrome during ovarian stimulation.J Assist Reprod Genet. 2018 Dec;35(12):2187-2193. doi: 10.1007/s10815-018-1314-2. Epub 2018 Sep 19. J Assist Reprod Genet. 2018. PMID: 30232642 Free PMC article.
-
Nephrotic sydrome developing in severe ovarian hyperstimulation syndrome.Int J Fertil Steril. 2014 Jan;7(4):345-8. Epub 2013 Dec 22. Int J Fertil Steril. 2014. PMID: 24520505 Free PMC article.
-
Dual trigger protocol is an effective in vitro fertilization strategy in both normal and high responders without compromising pregnancy outcomes in fresh cycles.F S Rep. 2021 May 27;2(3):314-319. doi: 10.1016/j.xfre.2021.05.008. eCollection 2021 Sep. F S Rep. 2021. PMID: 34553157 Free PMC article.
-
The Therapeutic Potential of EGCG and Pro-EGCG in Mitigating Ovarian Hyperstimulation Syndrome: Unraveling the Modulatory Mechanism through the VEGF Pathway.Int J Biol Sci. 2025 Apr 22;21(7):3045-3060. doi: 10.7150/ijbs.98653. eCollection 2025. Int J Biol Sci. 2025. PMID: 40384868 Free PMC article.
-
Optimal usage of the GnRH antagonists: a review of the literature.Reprod Biol Endocrinol. 2013 Mar 15;11:20. doi: 10.1186/1477-7827-11-20. Reprod Biol Endocrinol. 2013. PMID: 23496864 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical